ASPR issues supplemental information on REGEN-COV packaging, labeling and storage

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response today issued details on several key changes related to the REGEN-COV COVID-19 monoclonal antibody therapy. According to ASPR, hospitals receiving this week’s shipment of REGEN-COV should note that it will arrive in one of two packaging configurations: REGEN-COV Dose Packs (2 Vial) or Casirivimab and Imdevimab Co Pack (2 vials per carton). ASPR says REGEN-COV in both packaging configurations may be used to prepare and administer intravenous infusions as well as subcutaneous injections. Additional dosing and administration information can be found here.